BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 25745821)

  • 1. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
    Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
    Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.
    Ueda N; Takasawa K
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30150549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
    Ganz T; Nemeth E
    Semin Nephrol; 2016 Mar; 36(2):87-93. PubMed ID: 27236128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in iron status and hepcidin expression in rats.
    Kong WN; Niu QM; Ge L; Zhang N; Yan SF; Chen WB; Chang YZ; Zhao SE
    Biol Trace Elem Res; 2014 Aug; 160(2):258-67. PubMed ID: 24962641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
    Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
    Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
    Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
    Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial.
    Gaillard CA; Bock AH; Carrera F; Eckardt KU; Van Wyck DB; Bansal SS; Cronin M; Meier Y; Larroque S; Roger SD; Macdougall IC
    PLoS One; 2016; 11(6):e0157063. PubMed ID: 27276035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute-Phase Proteins and Iron Status in Cats with Chronic Kidney Disease.
    Javard R; Grimes C; Bau-Gaudreault L; Dunn M
    J Vet Intern Med; 2017 Mar; 31(2):457-464. PubMed ID: 28140480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa.
    Nalado AM; Olorunfemi G; Dix-Peek T; Dickens C; Khambule L; Snyman T; Paget G; Mahlangu J; Duarte R; George J; Naicker S
    BMC Nephrol; 2020 Sep; 21(1):415. PubMed ID: 32993549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peering into the future: hepcidin testing.
    Goyal J; McCleskey B; Adamski J
    Am J Hematol; 2013 Nov; 88(11):976-8. PubMed ID: 23798368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.
    Nekhai S; Xu M; Foster A; Kasvosve I; Diaz S; Machado RF; Castro OL; Kato GJ; Taylor JG; Gordeuk VR
    Haematologica; 2013 Mar; 98(3):455-63. PubMed ID: 23065513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond.
    Ueda N; Takasawa K
    Curr Med Chem; 2017; 24(14):1417-1452. PubMed ID: 28302014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney disease.
    Niihata K; Tomosugi N; Uehata T; Shoji T; Mitsumoto K; Shimizu M; Kawabata H; Sakaguchi Y; Suzuki A; Hayashi T; Okada N; Isaka Y; Rakugi H; Tsubakihara Y
    Nephrol Dial Transplant; 2012 Dec; 27(12):4378-85; discussion 4384-5. PubMed ID: 22833619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
    Kim IY; Kim JH; Lee DW; Lee SB; Rhee H; Song SH; Seong EY; Kwak IS
    Clin Exp Nephrol; 2018 Feb; 22(1):28-34. PubMed ID: 28389813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
    Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
    J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin.
    Ganz T
    Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between hepcidin, haemoglobin level and iron status in stage 4 chronic kidney disease patients with anaemia.
    Mogadam RA; Nemati A; Amani F; Ghorbanihaghjo A; Argani H; Bashardoust B
    J Pak Med Assoc; 2015 Apr; 65(4):354-7. PubMed ID: 25976565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease.
    Bahrainwala J; Berns JS
    Semin Nephrol; 2016 Mar; 36(2):94-8. PubMed ID: 27236129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body iron transport and metabolism: Mechanistic, multi-scale model to improve treatment of anemia in chronic kidney disease.
    Sarkar J; Potdar AA; Saidel GM
    PLoS Comput Biol; 2018 Apr; 14(4):e1006060. PubMed ID: 29659573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.